News for 'bioscience'

Dr Reddy's diabetic drug shows promising results

Dr Reddy's diabetic drug shows promising results

Rediff.com5 Jan 2010

The Indian drug industry's dream of coming out with an own new chemical entity or an originally researched new drug has received a big boost. Balaglitazone, the diabetic drug molecule being developed by Dr Reddy's Laboratories, has showed encouraging results in the final lap of human clinical trials.

Ranbaxy finding ways to make acquisitions work

Ranbaxy finding ways to make acquisitions work

Rediff.com16 Nov 2009

Ranbaxy, originally promoted by the Singh family, was acquired by Japan's Daiichi Sankyo late last year.

Covaxin output scaled up to 500 million jabs a year: Bharat Biotech

Covaxin output scaled up to 500 million jabs a year: Bharat Biotech

Rediff.com17 May 2021

This apart, to further increase capacities, Bharat Biotech has partnered with Indian Immunologicals (IIL) to manufacture the drug substance for Covaxin. The technology transfer process is underway and IIL has the 'capabilities and expertise' to manufacture the inactivated viral vaccines at commercial scale.

CIMAP opens PhD admissions

CIMAP opens PhD admissions

Rediff.com24 Jun 2008

Central Institute of Medicinal and Aromatic Plants (CIMAP) opens admissions to its PhD programme.

Govt sponsored associateships for young scientists

Govt sponsored associateships for young scientists

Rediff.com11 Oct 2007

The Government of India's Department of Biotechnology offers Assocatiateship for Young Scientists 2007-2008

ASK AJIT: Will these shares make me rich?

ASK AJIT: Will these shares make me rich?

Rediff.com30 Dec 2021

Ajit Mishra, vice president, research, Religare Broking, answers your stockmarket queries.

A career in patent law

A career in patent law

Rediff.com13 Jul 2006

: Shri Vile Parle Kelavani Mandal's Institute of Intellectual Property Studies, Mumbai, invites applications for its one year Post-graduate Diploma in Patent Law and Practice and a four-month Certificate Course in Intellectual Property.

'Man mission to space to have 3 members; will be in space for 5-7 days'

'Man mission to space to have 3 members; will be in space for 5-7 days'

Rediff.com28 Aug 2018

India will be the fourth country after the United States, Russia and China to send humans to space.

Masters programme in public health

Masters programme in public health

Rediff.com27 Jun 2006

National Institute of Communicable Diseases, Directorate General of Health Services, invites applications for admission to its two-year Master of Public Health (Field Epidemiology) programme

Second Covid wave won't end before July: Virologist

Second Covid wave won't end before July: Virologist

Rediff.com11 May 2021

Eminent virologist Shahid Jameel COVID-19 cases in the second wave also won't come down in as steady a fashion as they did after the first wave.

Mumbai airport: What will it be like

Mumbai airport: What will it be like

Rediff.com3 Jan 2008

G V Sanjay Reddy, vice chairman of the GVK Group, elaborates on his plans for the much-awaited Mumbai airport makeover.

Ranbaxy buys 15% stake in Jupiter Bio

Ranbaxy buys 15% stake in Jupiter Bio

Rediff.com29 May 2007

Jupiter Bioscience, a manufacturer of specialised organic compounds, on Tuesday said it has allotted 14.91 per cent stake to Ranbaxy Laboratories through issue of share warrants on preferential basis for Rs 46.70 crore (Rs 467 billion).

PGD in clinical research

PGD in clinical research

Rediff.com8 Nov 2005

The Institute of Clinical Research invites applications for its one-year, part-time Post-graduate Diploma in Clinical Research.

Fortis to set up healthcare centre

Fortis to set up healthcare centre

Rediff.com8 Mar 2006

Kiran Mazumdar-Shaw among 'top 100 talented' people

Kiran Mazumdar-Shaw among 'top 100 talented' people

Rediff.com13 Jul 2015

Biocon CMD Kiran Mazumdar-Shaw has been named in the world's top 100 'effective and talented' people by US-based 'Scientific American' magazine.

Future's bright for Indian pharma cos

Future's bright for Indian pharma cos

Rediff.com7 Oct 2005

I would focus on R&D, correct or fine tune the US strategy and look at inorganic growth routes

From Shy Kid To Rhodes Scholar: Ritika Mukherji's Journey

From Shy Kid To Rhodes Scholar: Ritika Mukherji's Journey

Rediff.com17 Jan 2022

It's not every day that an undergraduate from India wins a scholarship to study at one of the prestigious universities in the world.

The big small brands

The big small brands

Rediff.com19 Jul 2003

Tax evasion through stocks: Sebi revokes ban on 114 entities

Tax evasion through stocks: Sebi revokes ban on 114 entities

Rediff.com20 Sep 2017

Violation of provisions of Sebi Act, Securities Contracts regulation, Prohibition of Fraudulent Trade (PFTUP) norms were not observed in respect of these 114 entities.

India biggest buyer of Covid vaccine with 1.6 bn doses

India biggest buyer of Covid vaccine with 1.6 bn doses

Rediff.com4 Dec 2020

India has purchased 500 million doses of the Oxford University-AstraZeneca vaccine candidate, one billion from the United States company Novavax and 100 million doses of the Sputnik V candidate from Russia's Gamaleya Research Institute, according to the US-based Duke University Global Health Innovation Center.

DON'T Undercount Covid Deaths!

DON'T Undercount Covid Deaths!

Rediff.com12 Jul 2021

Experts believe that under-reporting is likely to cause an underestimation of the spread of the disease.

Is 'localised' herd immunity behind dip in India's Covid count?

Is 'localised' herd immunity behind dip in India's Covid count?

Rediff.com5 Jan 2021

While there is a glimmer of hope and India's COVID-19 numbers are on a definite decline for a combination of reasons, a vaccination programme continues to be important, particularly given the presence of a mutant, more transmissible strain, several experts said while cautioning against infection upticks ahead.

Bengali actor, ex-TMC MP Tapas Paul dead

Bengali actor, ex-TMC MP Tapas Paul dead

Rediff.com18 Feb 2020

Paul, who was in Mumbai to visit his daughter, complained of chest pain at the Mumbai airport during his return to Kolkata and was rushed to a hospital in Juhu but died around 4 am, they said.

COVID-19: Is the worst over in India?

COVID-19: Is the worst over in India?

Rediff.com29 Dec 2020

'The worst is possibly over because too many of us may already be infected.'

ASK AJIT: Are these stocks good to hold for one year?

ASK AJIT: Are these stocks good to hold for one year?

Rediff.com1 Sep 2021

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.

Should post vaccine reactions be better monitored?

Should post vaccine reactions be better monitored?

Rediff.com17 May 2021

'There is more likelihood of dying from lightning than from vaccine induced blood clots.'

North India could see 100,000 cases per state per day

North India could see 100,000 cases per state per day

Rediff.com19 Apr 2021

'The trajectory of the disease will keep increasing because of the population density being very high.'

Slow march on the path to immortality

Slow march on the path to immortality

Rediff.com20 Oct 2019

Is it possible to extend lifespans to, say, 120 years, or longer, asks Devangshu Datta.

New single-dose Ebola vaccine shows promise

New single-dose Ebola vaccine shows promise

Rediff.com9 Apr 2015

Researchers have developed a quick-acting Ebola vaccine that is both safe and effective with a single dose

7 ways Indian startups will get a big boost

7 ways Indian startups will get a big boost

Rediff.com28 Sep 2015

IIM Ahmedabad's CIIE signed a MoU with Tata Trust for founding partner for the Bharat Fund, which will provide seed funding to Indian entrepreneurs.

India's rich club has only 4 women

India's rich club has only 4 women

Rediff.com22 Sep 2016

Savitri Jindal has retained the tag of being the richest woman in India with a networth of $5.2 billion

'Surveillance can't go down because the curve is going down'

'Surveillance can't go down because the curve is going down'

Rediff.com29 Dec 2020

'Even after vaccines are given, precautions like using a mask and maintaining social distancing have to be taken.'

Apple iPad 2018: An education-centric tablet

Apple iPad 2018: An education-centric tablet

Rediff.com23 May 2018

The latest avatar of the iPad, at least outwardly, is a dead ringer for its predecessor from last year. The biggest change, however, is support for the stylus, says Abhik Sen.

Entrepreneurs support crucial for 'Make in India' campaign

Entrepreneurs support crucial for 'Make in India' campaign

Rediff.com17 Nov 2014

John Holdren, Director, White House Office of Science and Technology Policy, said the two countries were working in the fields of space, medical sciences, climate change, clean energy and agriculture.

Markets plunge: 263 stocks crash on BSE

Markets plunge: 263 stocks crash on BSE

Rediff.com20 Aug 2013

In line with a weak stock market where benchmark Sensex plunged nearly 300 points, as many as 263 stocks hit their respective one-year lows on BSE on Monday.

A 4-point formula to boost farm economy

A 4-point formula to boost farm economy

Rediff.com20 Feb 2019

The formula for success of farm economy is very simple -- farmers should be able to produce more from the same piece of land at reduced cost while minimising risk and be connected to market to get higher realisation for their produce, points out Siraj Chaudhry.

Alkem fudged trial data: German regulator

Alkem fudged trial data: German regulator

Rediff.com16 Apr 2016

The European Medicines Agency's review is the second setback to Alkem Laboratories

Markets end flat amid volatility; IT shares weigh

Markets end flat amid volatility; IT shares weigh

Rediff.com27 Jun 2016

FII stance, progress of monsoon, crude oil and rupee movement are likely to dictate the trend.

Pharma shares boost markets; Dr Reddy's Labs, Lupin lead

Pharma shares boost markets; Dr Reddy's Labs, Lupin lead

Rediff.com6 Aug 2015

Asian markets were trading mixed with the Nikkei gaining after the US dollar strengthened against the yen.